References
- Pyorala K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologicview. Diabetes Metab Rev. 1987; 3: 463–524
- Kannel W. B., McGee D. L. Diabetes and Cardiovascular disease: the Framingham study. JAMA 1979; 241: 2035–2038
- Howard B. V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987; 28: 613–628
- West K. M., Ahuja M. M.S., Bennett P.H. The role of ciruclating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361–369
- Laakso M., Voutlainen E., Pyorala K., Sarlund H. Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics. Arteriosclerosis 1985; 5: 653–658
- Takegoshi T., Haba T., Hirai J., et al. Alterations of lipoprotein(a) in patients with diabetic nephropathy (Letter). Atherosclerosis 1990; 83: 99–100
- Brunzell J. D., Sniderman A. D., Albers J. J., Kwiterovich P. O. Apoproteins B and A-1 coronary artery disease in humans. Arteriosclerosis 1984; 4: 79–83
- DeFronzo R. A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194
- Kaplan N. M. The deadly quatlet upper body obesity glucose intolerance hypertriglyceridemia and hypertension. Arch Intern Med. 1989; 149: 1514–1520
- Fuljioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54–59
- Reaven G. M. Insulin resistance hyperinsullinemia hypertriglyceridemia and hypertension parallels between human disease and rodent models. Diabetes Care 1991; 14: 195–202
- LePape A., Guitton J. D., Gutman N., et al. Nonenzymatic glucosylation of collagen in diabetes: incidence on increased normal platelet aggregation. Haemostasis 1983; 13: 36–41
- Kirstein M., Brett J., Radoff S., et al. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990; 87: 9010–9014
- Vlassara H., Brownlee M., Manogue K. R., et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 1988; 240: 1546–1548
- Kitahara M., Eyre H. J., Lynch R. E., et al. Metabolic activity of diabetic monocytes. Diabetes 1980; 29: 251–256
- Witztum J. L., Koschinsky T. Metabolic and immunological consequences of glycation of low density lipoproteins. Prog Clin Biol Res. 1989; 304: 219–234